Biotech · Private company
BioNTech US Inc.
Track this companyFree. Adds BioNTech US Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- AdjuvantPhase 1 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- AdjuvantPhase 1 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- AdjuvantPhase 1 · Urinary Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- APX005MPhase 1 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 1 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- ipilimumabPhase 1 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- NEO-PV-01Phase 1 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- NEO-PV-01Phase 1 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- NEO-PV-01Phase 1 · Urinary Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 1 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 1 · Urinary Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- PemetrexedPhase 1 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced MelanomaPHASE1 · TERMINATED · started Oct 8, 2018ClinicalTrials.gov NCT03597282 · fetched Nov 12, 2026
- A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung CancerPHASE1 · COMPLETED · started May 4, 2018ClinicalTrials.gov NCT03380871 · fetched Nov 12, 2026
- A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder CancerPHASE1 · COMPLETED · started Oct 1, 2016ClinicalTrials.gov NCT02897765 · fetched Nov 12, 2026